113 related articles for article (PubMed ID: 2124180)
1. Hemostatic changes in women using a monthly injectable contraceptive for one year.
Meng YX; Jiang HY; Chen AJ; Lu FY; Yang H; Zhang MY; Shen KY; Sun DL; Shao QX; Fotherby K
Contraception; 1990 Oct; 42(4):455-66. PubMed ID: 2124180
[TBL] [Abstract][Full Text] [Related]
2. Effect of norethisterone enanthate on endometrial bleeding and changes in coagulation function, ovarian hormones and endometrial histology in Thai women.
Meng YX; Virutamasen P
Contraception; 1991 Jul; 44(1):73-82. PubMed ID: 1893702
[TBL] [Abstract][Full Text] [Related]
3. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.
Haiba NA; el-Habashy MA; Said SA; Darwish EA; Abdel-Sayed WS; Nayel SE
Contraception; 1989 Jun; 39(6):619-32. PubMed ID: 2666019
[TBL] [Abstract][Full Text] [Related]
5. The effects of intramuscular norethisterone oenanthate used as a contraceptive on intravenous glucose tolerance and on blood coagulation factors VII and X.
Howard G; Myatt L; Elder MG
Br J Obstet Gynaecol; 1977 Aug; 84(8):618-21. PubMed ID: 889752
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulaion
Contraception; 2003 Sep; 68(3):159-76. PubMed ID: 14561536
[TBL] [Abstract][Full Text] [Related]
7. Long-term use of depot-norethisterone enanthate: effect on blood coagulation factors and menstrual bleeding patterns.
McEwan JA; Griffin M
Contraception; 1991 Dec; 44(6):639-48. PubMed ID: 1773620
[TBL] [Abstract][Full Text] [Related]
8. The effects of long-term using once-a-month injectable contraceptive norethisterone enanthate/estradiol valerate on coagulation in the Chinese.
Meng YX; Jiang HY; Lu FY
Thromb Haemost; 1990 Dec; 64(4):548-9. PubMed ID: 2084940
[TBL] [Abstract][Full Text] [Related]
9. Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
Bull World Health Organ; 1993; 71(6):677-89. PubMed ID: 8313486
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin.
Garza-Flores J; Alba VM; Cravioto MC; Hernandez L; Perez-Palacios G; Alvarado G; Rivera R; Recio R; Bassol S
Contraception; 1989 May; 39(5):519-29. PubMed ID: 2524362
[TBL] [Abstract][Full Text] [Related]
11. The effects of Norplant on clinical chemistry in Singaporean acceptors after 1 year of use: I. Haemostatic changes.
Viegas OA; Singh K; Koh S; Singh P; Ratnam SS
Contraception; 1988 Sep; 38(3):313-23. PubMed ID: 3139360
[TBL] [Abstract][Full Text] [Related]
12. Progestational agents and blood coagulation. VIII. Effect of low-dose, alternate-day, estrogen-progestin combinations on blood coagulation factors in man, with a special note on the effect of freezing of blood samples.
Ambrus JL; Courey NG; Browne BJ; Mink IB; Moore RH; Ambrus CM
Am J Obstet Gynecol; 1977 May; 128(2):161-6. PubMed ID: 857675
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of combined oral contraceptive preparations.
Singh BM; Nutter SA; Nattrass M
Contraception; 1987 Dec; 36(6):651-8. PubMed ID: 3128428
[TBL] [Abstract][Full Text] [Related]
14. Mesigyna once-a-month combined injectable contraceptive: experience in Latin America.
Bassol S; Cravioto MC; Durand M; Bailon R; Carranza S; Fugarolas J; Gaona R; Parada LM; Celis C; Santoyo S; Garza-Flores J; Vazquez L; Lopez C; Gurucharri C; Novelli J; Carneiro de Oliveira H; Mendez J; de Andrade ME; de Mello NR; de Melo K; Chada E; Yassle ME; Castañeda A; Gomez P; Arboleda C; Trujillo L; Bucheli R; Hidalgo I; Olavide R; Parejarios J; Succar J; Reyes-Marquez R; Albrecht G
Contraception; 2000 May; 61(5):309-16. PubMed ID: 10906501
[TBL] [Abstract][Full Text] [Related]
15. Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna.
Seibert B; Günzel P
Contraception; 1994 Apr; 49(4):303-33. PubMed ID: 8013217
[TBL] [Abstract][Full Text] [Related]
16. Effect of norethisterone enanthate on the blood count and endometrial histology of Indian women.
Chaudhuri C; Dutta SK; Mukherjea M
Contraception; 1985 Oct; 32(4):417-28. PubMed ID: 3907969
[TBL] [Abstract][Full Text] [Related]
17. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
18. Some metabolic and hormonal changes in women using long acting injectable contraceptives.
Abdel-sayed WS; Toppozada HK; Said SA; El-sayed OK
Alex J Pharm Sci; 1989 Mar; 3(1):29-32. PubMed ID: 12316139
[TBL] [Abstract][Full Text] [Related]
19. Existing once-a-month combined injectable contraceptives.
Toppozada MK
Contraception; 1994 Apr; 49(4):293-301. PubMed ID: 8013216
[TBL] [Abstract][Full Text] [Related]
20. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Wilson ES; Cruickshank J; McMaster M; Weir RJ
Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
